文献速递血栓与止血

深静脉血栓形成中的代谢通路:治疗干预的新前沿

Metabolic pathways in deep vein thrombosis: a new frontier for therapeutic intervention.
PubMed 文献 · Blood · 2025-01-01

本综述总结深静脉血栓形成(DVT)中内皮细胞、中性粒细胞和血小板的代谢重编程(糖酵解、磷酸戊糖途径和氧化还原平衡变化),并汇总临床前DVT模型证据,显示靶向代谢通路可减少静脉血栓形成而不损害止血,提出以代谢为中心的治疗新思路。

要点

  • DVT是炎症驱动的复杂过程,内皮细胞、中性粒细胞和血小板在起始中起主要作用。
  • 这些细胞在淤滞、缺氧和炎症刺激下发生代谢重编程,涉及糖酵解、磷酸戊糖途径和氧化还原平衡。
  • 临床前DVT模型显示靶向代谢通路可减少静脉血栓形成而不损害止血。

核心结论

  • 通过调控驱动促血栓和促炎表型的代谢通路,可能预防DVT起始或限制其进展,同时减少对 anticoagulants 的依赖及相关出血风险。

研究设计与样本

  • 综述,总结当前对DVT中代谢适应的认识,并检查临床前DVT模型的证据。

主要发现

  • DVT是炎症驱动的复杂过程而非仅依赖凝血的血栓形成,内皮细胞、中性粒细胞和血小板在起始中起主要作用。
  • 这些细胞在淤滞、缺氧和炎症刺激下发生代谢重编程,包括糖酵解、磷酸戊糖途径和氧化还原平衡的变化。
  • 临床前DVT模型证据显示靶向代谢通路可减少静脉血栓形成而不损害止血。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Venous thromboembolism, which includes deep vein thrombosis (DVT) and pulmonary embolism, is a common cardiovascular disorder associated with significant morbidity and mortality. Current treatment options primarily involve anticoagulants, which reduce the risk of fatal events and DVT recurrence but increase the risk of bleeding, particularly in people requiring prolonged thromboprophylaxis. Growing evidence characterizes DVT as a complex inflammation-driven process rather than a merely coagulation-dependent thrombosis, with endothelial cells, neutrophils, and platelets playing major roles in its initiation. Recent studies demonstrate that these cell types undergo profound metabolic reprogramming in response to stasis, hypoxia, and inflammatory stimuli, including shifts in glycolysis, the pentose phosphate pathway, and redox balance. This review summarizes current insights into these metabolic adaptations, examines evidence from preclinical DVT models showing that targeting metabolic pathways can reduce venous thrombus formation without impairing hemostasis, and highlights potential metabolic targets for intervention. By modulating metabolic pathways that underlie the prothrombotic and proinflammatory phenotypes, it may be possible to prevent DVT initiation or limit its progression while reducing the reliance on anticoagulants and the risk of associated bleeding complications. This metabolism-centered perspective opens new avenues for the development of safer, more effective treatments for DVT.

来源:Blood,查看原文。版权归原作者所有。

引用

  1. Budnik I, Kumskova M, Chauhan AK, et al. Metabolic pathways in deep vein thrombosis: a new frontier for therapeutic intervention. Blood. 2025. PMID: 40132161. doi:10.1182/blood.2024027636

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。